DECOR Information for Project: ANS-Modèles de contenus CDA (BBR) (BBR-) |
| HTML | Name | Effective Date | Version Label |
|---|---|---|---|
| html | _0272 2.16.840.1.113883.1.11.19686
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Testing to measure the minimum concentr... | |||
| html | _0275a 2.16.840.1.113883.1.11.19687
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 | |||
| html | _0280 2.16.840.1.113883.1.11.19688
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Test methods designed to determine a mi... | |||
| html | ActPriority 2.16.840.1.113883.1.11.16866
ref
ccda-
|
2016‑06‑23 | |
| html | ActStatus 2.16.840.1.113883.1.11.15933
ref
ad2bbr-
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Contains the names (codes) for each of ... | |||
| html | ActSubstanceAdministrationCode 2.16.840.1.113883.1.11.19708
ref
ad2bbr-
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Describes the type of substance adminis... | |||
ActSubstanceAdministrationImmunizationCode 2.16.840.1.113883.1.11.19709
|
Multiple (2) | ||
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: The introduction of an immunogen with t... | |||
| html | ActSubstanceAdministrationImmunizationCode 2.16.840.1.113883.1.11.19709
ref
ad2bbr-
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| html | JDV_HL7_ActSubstanceAdministrationImmunizationCode_CISIS 2.16.840.1.113883.1.11.19709
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20100101000000 |
| html | Administration Unit Dose Form 2.16.840.1.113762.1.4.1021.30
ref
ccda-
|
2013‑01‑31 | |
| Codes that are similar to a drug "form" but limited to those used as units when describing drug administration when the drug item is a physical form that is continuous and therefore not administered a... | |||
| html | Administrative Gender (HL7 V3) 2.16.840.1.113883.1.11.1
ref
ccda-
|
2016‑06‑23 | |
| html | Body Site 2.16.840.1.113883.3.88.12.3221.8.9
ref
ccda-
|
2013‑01‑31 | |
| html | Clinical Substance 2.16.840.1.113762.1.4.1010.2
ref
ccda-
|
2013‑01‑31 | |
| All substances that may need to be represented in the context of health care related activities. This value set is quite broad in coverage and includes concepts that may never be needed in a health ca... | |||
| html | Country 2.16.840.1.113883.3.88.12.80.63
ref
ccda-
|
2013‑01‑31 | |
| html | CVX Vaccines Administered - Vaccine Set 2.16.840.1.113762.1.4.1010.6
ref
ccda-
|
2013‑01‑31 | |
| Value Set: CVX Vaccines Administered - Vaccine Set 2.16.840.1.113762.1.4.1010.6 CVX vaccine concepts that represent actual vaccines types. This does not include the identifiers for CVX codes that do n... | |||
| html | DecisionObservationMethod 2.16.840.1.113883.1.11.19378
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Provides codes for decision methods, in... | |||
| html | GeneticObservationMethod 2.16.840.1.113883.1.11.20290
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: A code that provides additional detail ... | |||
| html | Healthcare Provider Taxonomy 2.16.840.1.114222.4.11.1066
ref
ccda-
|
2019‑05‑21 | |
| (Clinical Focus: Represent the "type" of health care provider individual or organization using the National Uniform Claims Committee (NUCC) code system),(Data Element Scope: The assignedEntity attribu... | |||
| html | HealthcareServiceLocation 2.16.840.1.113883.1.11.20275
ref
ccda-
|
2016‑06‑23 | |
| html | JDV_AbsentOrUnknownImmunization_CISIS 1.2.250.1.213.1.1.5.666
ref
CI-SIS-JDV-
|
2021‑12‑22 | 20211222000000 |
| html | JDV_AbsentOrUnknownMedication_CISIS 1.2.250.1.213.1.1.5.664
ref
CI-SIS-JDV-
|
2021‑12‑22 | 20211222000000 |
| html | JDV_CodesDocumentImagerie_CISIS 1.2.250.1.213.1.1.5.687
ref
CI-SIS-JDV-
|
2022‑08‑05 | 20240731000000 |
| html | JDV_CompletudeDispensation_CISIS 1.2.250.1.213.1.1.5.765
ref
CI-SIS-JDV-
|
2023‑12‑21 | 20231221000000 |
| html | JDV_CouvertureSociale_CISIS 1.2.250.1.213.1.1.5.125
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20231019000000 |
| html | JDV_EvaluationDepressionGeriatrique30_CISIS 1.2.250.1.213.1.1.5.511
ref
CI-SIS-JDV-
|
2020‑07‑09 | 20200709000000 |
| html | JDV_EvaluationDouleur_CISIS 1.2.250.1.213.1.1.5.499
ref
CI-SIS-JDV-
|
2020‑05‑07 | 20200511000000 |
| html | JDV_FluideRouteCodes_CISIS 1.2.250.1.213.1.1.5.684
ref
CI-SIS-JDV-
|
2022‑04‑12 | 20220412000000 |
| html | JDV_FonctionEtudieeScintigraphie_CISIS 1.2.250.1.213.1.1.5.669
ref
CI-SIS-JDV-
|
2022‑01‑26 | 20230202000000 |
| html | JDV_FonctionEtudieeTEP_CISIS 1.2.250.1.213.1.1.5.668
ref
CI-SIS-JDV-
|
2022‑01‑26 | 20230202000000 |
| html | JDV_HealthStatusCodes_CISIS 1.2.250.1.213.1.1.4.2.283.1
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20231114000000 |
| html | JDV_HL7_ActMood_CISIS 2.16.840.1.113883.1.11.10196
ref
CI-SIS-JDV-
|
2024‑09‑05 | 20240905000000 |
| html | JDV_HL7_ActSubstanceAdminSubstitutionCode_CISIS 2.16.840.1.113883.1.11.16621
ref
CI-SIS-JDV-
|
2020‑03‑13 | 20200313000000 |
| html | JDV_HL7_allergy_intolerance_criticality_CISIS 2.16.840.1.113883.4.642.3.129
ref
CI-SIS-JDV-
|
2022‑01‑01 | 20220101000000 |
| html | JDV_HL7_allergyintolerance_clinical_CISIS 2.16.840.1.113883.4.642.3.1372
ref
CI-SIS-JDV-
|
2022‑01‑01 | 20220101000000 |
| html | JDV_HL7_condition_ver_status_CISIS 2.16.840.1.113883.4.642.3.166
ref
CI-SIS-JDV-
|
2022‑01‑01 | 20240606000000 |
| html | JDV_HL7_ConditionClinical_CISIS 2.16.840.1.113883.4.642.3.164
ref
CI-SIS-JDV-
|
2022‑01‑01 | 20220101000000 |
| html | JDV_HL7_employmentStatus_CISIS 2.16.840.1.113883.1.11.20562
ref
CI-SIS-JDV-
|
2019‑01‑01 | 20190101000000 |
| html | JDV_HL7_SpecimenAdditiveEntity_CISIS 2.16.840.1.113883.1.11.16042
ref
CI-SIS-JDV-
|
2020‑01‑18 | 20200118000000 |
| html | JDV_HL7_SpecimenRoleType_CISIS 2.16.840.1.113883.1.11.16515
ref
CI-SIS-JDV-
|
2020‑01‑18 | 20200118000000 |
| html | JDV_HL7_SpecimenType_CISIS 2.16.840.1.113883.21.327
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20240126000000 |
| html | JDV_HL7_WorkSchedule_CISIS 2.16.840.1.113883.1.11.20561
ref
CI-SIS-JDV-
|
2019‑01‑01 | 20190101000000 |
| html | JDV_HumanSubstanceAdministrationSite_CISIS 1.2.250.1.213.1.1.5.686
ref
CI-SIS-JDV-
|
2022‑05‑09 | 20221121000000 |
| html | JDV_ImagerieObjectifsReference_CISIS 1.2.250.1.213.1.1.5.672
ref
CI-SIS-JDV-
|
2022‑02‑17 | 20220217000000 |
| html | JDV_ImmunizationApproachSiteCode_CISIS 1.2.250.1.213.1.1.5.621
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20231114000000 |
| html | JDV_ImmunizationRouteCodes_CISIS 1.2.250.1.213.1.1.5.676
ref
CI-SIS-JDV-
|
2022‑03‑25 | 20220325000000 |
| html | JDV_Importance_clinique_CISIS 1.2.250.1.213.1.1.5.153
ref
CI-SIS-JDV-
|
2019‑04‑01 | 20240315000000 |
| html | JDV_InjectionPDC_TEP_CISIS 1.2.250.1.213.1.1.5.670
ref
CI-SIS-JDV-
|
2022‑01‑26 | 20220126000000 |
| html | JDV_J01_XdsAuthorSpecialty_CISIS 1.2.250.1.213.1.1.5.461
ref
CI-SIS-JDV-
|
2012‑11‑12 | 20240329000000 |
| html | JDV_J02_XdsHealthcareFacilityTypeCode_CISIS 1.2.250.1.213.1.1.5.466
ref
CI-SIS-JDV-
|
2014‑10‑08 | 20240726000000 |
| html | JDV_J04_XdsPracticeSettingCode_CISIS 1.2.250.1.213.1.1.5.467
ref
CI-SIS-JDV-
|
2010‑11‑04 | 20240927000000 |
| html | JDV_J11_RelationPatient_CISIS 1.2.250.1.213.3.3.16
ref
CI-SIS-JDV-
|
2016‑09‑01 | 20200424000000 |
| html | JDV_J47_FunctionCode_CISIS 1.2.250.1.213.1.1.5.124
ref
CI-SIS-JDV-
|
2018‑03‑30 12:00:00 | 20240126000000 |
| html | JDV_Lateralite_CISIS 1.2.250.1.213.1.1.5.160
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20221216000000 |
| html | JDV_Lien_Assure_Beneficiaire_CISIS 1.2.250.1.213.1.1.5.126
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20100101000000 |
| html | JDV_LocalisationAnatomique_CISIS 1.2.250.1.213.1.1.5.694
ref
CI-SIS-JDV-
|
2023‑06‑01 | 20230601000000 |
| html | JDV_MediaType_ObservationMedia_CISIS 1.2.250.1.213.1.1.5.503
ref
CI-SIS-JDV-
|
2020‑06‑26 | 20200626000000 |
| html | JDV_MesureLentilleDelivree_CISIS 1.2.250.1.213.1.1.5.656
ref
CI-SIS-JDV-
|
2021‑09‑24 | 20230330000000 |
| html | JDV_MesureLentillePrescrite_CISIS 1.2.250.1.213.1.1.5.655
ref
CI-SIS-JDV-
|
2021‑09‑24 | 20230725000000 |
| html | JDV_MesureTypeVerreDelivre_CISIS 1.2.250.1.213.1.1.5.654
ref
CI-SIS-JDV-
|
2021‑09‑24 | 20210924000000 |
| html | JDV_MesureTypeVerrePrescrit_CISIS 1.2.250.1.213.1.1.5.652
ref
CI-SIS-JDV-
|
2021‑09‑24 | 20210924000000 |
| html | JDV_MesureVerreDelivre_CISIS 1.2.250.1.213.1.1.5.653
ref
CI-SIS-JDV-
|
2021‑09‑24 | 20230330000000 |
| html | JDV_MesureVerrePrescrit_CISIS 1.2.250.1.213.1.1.5.651
ref
CI-SIS-JDV-
|
2021‑09‑24 | 20230330000000 |
| html | JDV_MethodeDeMesureAcuiteVisuelle_CISIS 1.2.250.1.213.1.1.5.715
ref
CI-SIS-JDV-
|
2022‑12‑19 | 20221219000000 |
| html | JDV_Modalite_demandeActeImagerie_CISIS 1.2.250.1.213.1.1.5.660
ref
CI-SIS-JDV-
|
2021‑12‑16 | 20211216000000 |
| html | JDV_ModaliteAcquisition_CISIS 1.2.250.1.213.1.1.5.618
ref
CI-SIS-JDV-
|
2021‑04‑19 | 20210419000000 |
| html | JDV_ModeDeTransport_CISIS 1.2.250.1.213.1.1.5.140
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20240902000000 |
| html | JDV_ModificateurTopographique_CISIS 1.2.250.1.213.1.1.5.688
ref
CI-SIS-JDV-
|
2022‑11‑14 | 20221114000000 |
| html | JDV_Morphologie_CISIS 1.2.250.1.213.1.1.5.585
ref
CI-SIS-JDV-
|
2021‑03‑01 | 20210301000000 |
| html | JDV_NIHSSAtaxInt_CISIS 1.2.250.1.213.1.1.5.187
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSConsInt_CISIS 1.2.250.1.213.1.1.5.179
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSCvInt_CISIS 1.2.250.1.213.1.1.5.183
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSDysInt_CISIS 1.2.250.1.213.1.1.5.191
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSFonction_CISIS 1.2.250.1.213.1.1.5.178
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20100101000000 |
| html | JDV_NIHSSLangInt_CISIS 1.2.250.1.213.1.1.5.188
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSLoccInt_CISIS 1.2.250.1.213.1.1.5.181
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSLocqInt_CISIS 1.2.250.1.213.1.1.5.180
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSMiInt_CISIS 1.2.250.1.213.1.1.5.186
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSMsInt_CISIS 1.2.250.1.213.1.1.5.185
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSNeglInt_CISIS 1.2.250.1.213.1.1.5.189
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSOculInt_CISIS 1.2.250.1.213.1.1.5.182
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSPfInt_CISIS 1.2.250.1.213.1.1.5.184
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_NIHSSSensInt_CISIS 1.2.250.1.213.1.1.5.190
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20220420000000 |
| html | JDV_OeilExamine_CISIS 1.2.250.1.213.1.1.5.627
ref
CI-SIS-JDV-
|
2021‑05‑07 | 20221216000000 |
| html | JDV_ParticipantAdditionnelResultat_CISIS 1.2.250.1.213.1.1.5.138
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20100101000000 |
| html | JDV_ProblemCodes_CISIS 1.2.250.1.213.1.1.5.172
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20240604000000 |
| html | JDV_QuantiteExpositionRayonnements_CISIS 1.2.250.1.213.1.1.5.620
ref
CI-SIS-JDV-
|
2021‑04‑19 | 20210419000000 |
| html | JDV_RouteofAdministration_CISIS 1.2.250.1.213.1.1.5.677
ref
CI-SIS-JDV-
|
2022‑03‑31 | 20220331000000 |
| html | JDV_ScoreBradenComponent_CISIS 1.2.250.1.213.1.1.5.504
ref
CI-SIS-JDV-
|
2020‑07‑06 | 20200706000000 |
| html | JDV_ScoreBradenResultat_CISIS 1.2.250.1.213.1.1.5.513
ref
CI-SIS-JDV-
|
2020‑07‑20 | 20200720000000 |
| html | JDV_SignesVitaux_CISIS 1.2.250.1.213.1.1.5.171
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20230403000000 |
| html | JDV_SocialHistoryCodes_CISIS 1.2.250.1.213.1.1.4.2.283.4
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20230330000000 |
| html | JDV_SOPClass_CISIS 1.2.250.1.213.1.1.5.689
ref
CI-SIS-JDV-
|
2022‑05‑14 | 20220514000000 |
| html | JDV_StatutDoc_CISIS 1.2.250.1.213.1.1.5.93
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20230131000000 |
| html | JDV_StatutQuorum_CISIS 1.2.250.1.213.1.1.4.2.281.16
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20100101000000 |
| html | JDV_Tumeur_CISIS 1.2.250.1.213.1.1.4.2.281.21
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20210922000000 |
| html | JDV_TypeDeMesureAcuiteVisuelle_CISIS 1.2.250.1.213.1.1.5.642
ref
CI-SIS-JDV-
|
2021‑06‑22 | 20230330000000 |
| html | JDV_TypeDeMesureDeRefraction_CISIS 1.2.250.1.213.1.1.5.641
ref
CI-SIS-JDV-
|
2021‑05‑07 | 20220919000000 |
| html | JDV_TypeDeMesureDispositifOculaire_CISIS 1.2.250.1.213.1.1.5.643
ref
CI-SIS-JDV-
|
2021‑06‑22 | 20240718000000 |
| html | JDV_TypeDirectiveAnticipee_CISIS 1.2.250.1.213.1.1.5.136
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20230803000000 |
| html | JDV_TypeDispositifOcculaire_CISIS 1.2.250.1.213.1.1.5.716
ref
CI-SIS-JDV-
|
2022‑12‑21 | 20221221000000 |
| html | JDV_TypeEvenementIndesirablePrevisible_CISIS 1.2.250.1.213.1.1.5.794
ref
CI-SIS-JDV-
|
2024‑06‑04 | 20240604000000 |
| html | JDV_TypeMotorisation_CISIS 1.2.250.1.213.1.1.5.801
ref
CI-SIS-JDV-
|
2024‑09‑02 | 20240902000000 |
| html | JDV_TypeTraitementIV_CISIS 1.2.250.1.213.1.1.5.173
ref
CI-SIS-JDV-
|
2010‑01‑01 | 20231114000000 |
| html | Medication Clinical Drug 2.16.840.1.113762.1.4.1010.4
ref
ccda-
|
2013‑01‑31 | |
| All prescribable medication formulations represented using either a "generic" or "brand-specific" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic bra... | |||
| html | Medication Route 2.16.840.1.113762.1.4.1099.12
ref
ccda-
|
2018‑07‑02 16:22:48 | 20170914 |
| Terms used to describe the path by which a substance is taken into the body. | |||
| html | Medication Route FDA 2.16.840.1.113883.3.88.12.3221.8.7
ref
ccda-
|
2013‑01‑31 | |
| html | MoodCodeEvnInt 2.16.840.1.113883.11.20.9.18
ref
ccda-
|
2016‑06‑23 | |
| html | ObservationInterpretation 2.16.840.1.113883.1.11.78
ref
ad2bbr-
|
2017‑12‑17 | DEFN=UV=VO=1402-20171217 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: One or more codes specifying a rough qu... | |||
| html | ObservationMethod 2.16.840.1.113883.1.11.14079
ref
ad2bbr-
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: A code that provides additional detail ... | |||
| html | ParticipationType 2.16.840.1.113883.1.11.10901
ref
ad2bbr-
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: A code specifying the meaning and purpo... | |||
| html | Patient Education 2.16.840.1.113883.11.20.9.34
ref
ccda-
|
2016‑06‑23 | |
| html | PersonalRelationshipRoleType 2.16.840.1.113883.1.11.19563
ref
ad2bbr-
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Types of personal relationships between... | |||
| html | PostalAddressUse 2.16.840.1.113883.1.11.10637
ref
ccda-
|
2016‑06‑23 | |
| html | PostalCode 2.16.840.1.113883.3.88.12.80.2
ref
ccda-
|
2013‑01‑31 | |
| html | Problem 2.16.840.1.113883.3.88.12.3221.7.4
ref
ccda-
|
2013‑01‑31 | |
| html | Problem Type 2.16.840.1.113883.3.88.12.3221.7.2
ref
ccda-
|
2016‑06‑23 | |
| html | Reaction Severity 2.16.840.1.113883.3.88.12.3221.6.8
ref
ccda-
|
2017‑10‑16 22:33:06 | |
| html | ROIOverlayShape 2.16.840.1.113883.1.11.16117
ref
ad2bbr-
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Shape of the region on the object being... | |||
| html | StateValueSet 2.16.840.1.113883.3.88.12.80.1
ref
ccda-
|
2013‑01‑31 | |
| html | UnitsOfMeasureCaseSensitive 2.16.840.1.113883.1.11.12839
ref
ad2bbr-
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Description: All units of measure. ... | |||
| html | Vaccine Clinical Drug 2.16.840.1.113762.1.4.1010.8
ref
ccda-
|
2013‑01‑31 | |
| html | VerificationMethod 2.16.840.1.113883.1.11.19707
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 | |||
| html | x_ActClassDocumentEntryAct 2.16.840.1.113883.1.11.19599
ref
ad2bbr-
|
2016‑11‑26 | DEFN=UV=VO=1382-20161126 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: The set of Act class codes allowed for ... | |||
| html | x_ActMoodDocumentObservation 2.16.840.1.113883.1.11.18943
ref
ad2bbr-
|
2016‑11‑26 | DEFN=UV=VO=1382-20161126 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Used to enumerate the moods that an obs... | |||
| html | x_AdverseEventCausalityAssessmentMethods 2.16.840.1.113883.1.11.19380
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Value set provides methods used to asse... | |||
| html | x_DocumentActMood 2.16.840.1.113883.1.11.19458
ref
ad2bbr-
|
2016‑11‑26 | DEFN=UV=VO=1382-20161126 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Used to enumerate the moods that an act... | |||
| html | x_DocumentProcedureMood 2.16.840.1.113883.1.11.19460
ref
ad2bbr-
|
2014‑03‑26 | DEFN=UV=VO=1360-20160323 |
| History description 2014-03-26: Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 description: Used to enumerate the moods that a proc... | |||
| HTML | Name | Effective Date | Version Label |
|---|
| HTML | Name | Effective Date | Version Label |
|---|
|
||||||||||||
Data sets, codes, OIDs and Rules: this information is used for rendering and validation purposes.